elkhunter Wednesday, 07/29/20 10:30:22 AM Re: None Post # of 42340 GAME OVER. Nothing to look forward to from the company until at least next year with the once again, perhaps, maybe, hopefully, dependent upon receiving adequate financing dream of commencing phase 1 trials. In the meantime another reverse split to remain on the OTC exchange (minimum of 1 cent requirement). No hope of up-listing to a major exchange even with a 1000:1 reverse split. Nathanielsz can continue filing patents all over the world but until PRP is shown to have some drug benefit without severe side-effects (phase 1 trials) everything is just hearsay and speculation generated by the company.